Home › Cambridge rare disease biotech Synageva to be acquired for $8.4B
 

Keywords :   


Cambridge rare disease biotech Synageva to be acquired for $8.4B

2015-05-06 13:59:14| Biotech - Topix.net

Cambridge rare disease biotech Synageva BioPharma Corp. will be acquired for $8.4 billion by Connecticut-based Alexion Pharmaceuticals, the two companies announced today.

Tags: disease rare acquired cambridge

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
23.11 SP 4
23.1122SSS64UL-S
23.11
23.11725 TYPE H
23.11 3
23.11 Studiologic NumaCompact2
23.11Switch EL Pro
23.11 22
More »